Characteristics Associated With Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence. Issue 12 (December 2017)

• Record Type: Journal Article
• Authors: Richter, Holly E.; Amundsen, C. L.; Erickson, S. W.; Jelovsek, J. E.; Komesu, Y.; Chermansky, C.; Harvie, H. S.; Albo, M.; Myers, D.; Gregory, W. T.; Wallace, D.
• Is Part Of: Obstetrical & gynecological survey. Volume 72:Issue 12(2017)
• Publication Date: 2017-12
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Surgery -- Periodicals; 618
• DOI: 10.1097/01.ogx.0000527551.60666.74
• Languages: English
• ISSNs: 0029-7828

Abstract

Abstract : (Abstracted from J Urol 2017;198:890–896) Primary treatment approaches for women with urgency urinary incontinence (UUI) include medications and behavioral therapy. Patients with UUI refractory to primary treatments may be offered third-line treatment options such as sacral neuromodulation (SNM) or onabotulinumtoxinA.